Cargando…
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
Primary liver cancer is predicted to be the sixth most common cancer and the fourth leading cause of cancer mortality worldwide. Recent studies identified nonalcoholic fatty liver disease (NAFLD) as the underlying cause in 13–38.2% of patients with hepatocellular carcinoma unrelated to viral hepatit...
Autor principal: | Sunami, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555727/ https://www.ncbi.nlm.nih.gov/pubmed/32947972 http://dx.doi.org/10.3390/ijms21186799 |
Ejemplares similares
-
Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022) -
Surveillance for Hepatocellular Carcinoma in Patients with NASH
por: Kolly, Philippe, et al.
Publicado: (2016) -
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
por: Pinter, Matthias, et al.
Publicado: (2023) -
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021) -
Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)